The role of mTOR pathway as target for treatment in adrenocortical cancer.

De Martino, Maria Cristina; Feelders, Richard A; Pivonello, Claudia; Simeoli, Chiara; Papa, Fortuna; Colao, Annamaria; Pivonello, Rosario; Hofland, Leo J

De Martino, Maria Cristina; Feelders, Richard A; Pivonello, Claudia; Simeoli, Chiara; Papa, Fortuna; Colao, Annamaria; Pivonello, Rosario; Hofland, Leo J.

Afiliación

De Martino MC; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Feelders RA; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy.
Pivonello C; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Simeoli C; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy.
Papa F; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy.
Colao A; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy.
Pivonello R; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy.
Hofland LJ; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy.

Endocr Connect ; 8(9): R144-R156, 2019 Sep.

Article en En | MEDLINE | ID: mdl-31398711

Palabras clave

adrenal; endocrine cancers; growth factors; neuroendocrinology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Endocr Connect Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google